This is the original version (as it was originally made).
Statutory Instruments
Medicines
Made
15th October 2020
Laid before Parliament
16th October 2020
Coming into force in accordance with regulation 1(2) and (3)
The Secretary of State and the Minister of Health in Northern Ireland make the following Regulations in exercise of the powers conferred by section 2(2) and (5) of the European Communities Act 1972(1). They have been designated for the purposes of section 2(2) of that Act in relation to medicinal products(2).
1972 c. 68. Section 2(2) was amended by section 27(1)(a) of the Legislative and Regulatory Reform Act 2006 (c. 51) and section 3(3) of, and Part 1 of the Schedule to, the European Union (Amendment) Act 2008 (c. 7). Section 2(5) was amended by section 41(1) of, and Part 1 of Schedule 6 to, the Northern Ireland Constitution Act 1973 (c. 36). Section 2 has been repealed by section 1 of the European Union (Withdrawal) Act 2018 (c. 16) (“the 2018 Act”) but, until IP completion day, it continues to have effect, by virtue of subsection (2) of section 1A of the 2018 Act (inserted by section 1 of the European Union (Withdrawal Agreement) Act 2020 (c. 1) (“the 2020 Act”)), as provided by subsections (3) to (5) of that section. For these purposes, “IP completion day” has the meaning given in section 39 of the 2020 Act.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
